Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Pharmaceutics|December 5, 2013
Advances in Lipid Nanoparticles for siRNA DeliveryYuen Yi C Tam, Sam Chen, Pieter R CullisNucleic Acid Therapeutics|April 24, 2018
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical UtilityJayesh A Kulkarni, Pieter R Cullis, Roy van der MeelLangmuir : the ACS Journal of Surfaces and Colloids|March 23, 2026
Hybrid Lipid Nanoparticles Containing Iron Oxide Nanoparticles and DoxorubicinIgor V Zhigaltsev, Arash Momeni, Yao Zhang, et al.Trends in Pharmacological Sciences|April 13, 2024
Direct in vivo CAR T cell engineeringLauralie Short, Robert A Holt, Pieter R Cullis, et al.Bioconjugate Chemistry|August 14, 2020
The Biomolecular Corona of Lipid Nanoparticles for Gene TherapyValentina Francia, Raymond M Schiffelers, Pieter R Cullis, et al.The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|September 11, 2012
Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured CoreAlex K K Leung, Ismail M Hafez, Svetlana Baoukina, et al.Advances in Genetics|November 21, 2014
Lipid nanoparticles for short interfering RNA deliveryAlex K K Leung, Yuen Yi C Tam, Pieter R CullisACS Nano|March 26, 2019
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene DeliveryJonas Buck, Philip Grossen, Pieter R Cullis, et al.Biochimica Et Biophysica Acta|September 13, 2002
Triggered release of doxorubicin following mixing of cationic and anionic liposomesIgor V Zhigaltsev, Norbert Maurer, Kim F Wong, et al.Journal of Liposome Research|June 24, 2008
Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulationsMichael J W Johnston, Katarina Edwards, Goran Karlsson, et al.Pageof 15